MedPath

INSTITUTE OF LIVER AND BILIARY SCIENCES

INSTITUTE OF LIVER AND BILIARY SCIENCES logo
šŸ‡®šŸ‡³India
Ownership
-
Employees
-
Market Cap
-
Website

Efficacy of Rectal Indomethacin in Prevention of Post-operative Pancreatitis After Pancreaticoduodenectomy

Not Applicable
Completed
Conditions
Pancreatoduodenectomy
Interventions
Other: Standard Medical Treatment
First Posted Date
2021-11-05
Last Posted Date
2022-07-06
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
44
Registration Number
NCT05109143
Locations
šŸ‡®šŸ‡³

Institute of Liver & Biliary Sciences, New Delhi, Delhi, India

Preoperative Sepsis Timeline, Profile and Its Association With Recipient Outcome Following Live Donor Liver Transplant

Conditions
Sepsis
Liver Transplant; Complications
Interventions
Other: This is an observational study
First Posted Date
2021-11-05
Last Posted Date
2022-01-26
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
500
Registration Number
NCT05109156
Locations
šŸ‡®šŸ‡³

Institute of Liver and Biliary Sciences, New Delhi, Delhi, India

Impact of Weight Loss in Cirrhosis With Obesity and MAFLD

Not Applicable
Recruiting
Conditions
Obesity
Liver Cirrhosis
Interventions
Other: Weight loss
First Posted Date
2021-11-03
Last Posted Date
2023-03-01
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
96
Registration Number
NCT05104541
Locations
šŸ‡®šŸ‡³

Institute of Liver and Biliary Sciences, New Delhi, Delhi, India

Effect of Branch Chain Amino Acid Therapy on Sarcopenia in Children With Chronic Liver Disease.

Not Applicable
Conditions
Sarcopenia
Cirrhosis, Liver
Interventions
Other: placebo
Dietary Supplement: branch chain amino acid
First Posted Date
2021-10-26
Last Posted Date
2021-11-03
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
44
Registration Number
NCT05093218
Locations
šŸ‡®šŸ‡³

Institiute of liver and biliary sciences, New Delhi, India

A Study to Assess the Impact of Implementing Modified Early Warning Score in Terms of Competency and Self-efficacy of Nurses at ILBS, Delhi

Not Applicable
Conditions
Liver Diseases
Interventions
Other: training porogram
First Posted Date
2021-10-21
Last Posted Date
2022-04-08
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
82
Registration Number
NCT05088044
Locations
šŸ‡®šŸ‡³

Institute of Liver & Biliary Sciences, New Delhi, Delhi, India

Efficacy and Safety of Midodrine in Refractory or Recurrent Ascites in Children With Cirrhosis.

Not Applicable
Withdrawn
Conditions
Refractory Ascites in Children With Cirrhosis
Interventions
Other: Standard medical treatment
First Posted Date
2021-10-19
Last Posted Date
2024-05-07
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Registration Number
NCT05084534
Locations
šŸ‡®šŸ‡³

ILBS, New Delhi, India

Effectiveness of Nurse-led Family Intervention on Stress, Engagement With Patient's Care and Satisfaction Among Primary Caregivers of Chronic Liver Disease Patients Admitted in High Dependency Unit of ILBS, New Delhi

Not Applicable
Conditions
Family Members of the Patients
Interventions
Other: Nurse-led family intervention
First Posted Date
2021-10-11
Last Posted Date
2022-04-14
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
80
Registration Number
NCT05073341
Locations
šŸ‡®šŸ‡³

Institute of Liver & Biliary Sciences, New Delhi, Delhi, India

Effect of Indo-Mediterranean Diet on Hepatic Steatosis and Fibrosis in NAFLD Children

Not Applicable
Completed
Conditions
Non-Alcoholic Fatty Liver Disease
Interventions
Other: Calorie restricted diet
Other: Indo Mediterranean diet
First Posted Date
2021-10-11
Last Posted Date
2023-10-16
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
39
Registration Number
NCT05073588
Locations
šŸ‡®šŸ‡³

Institute of liver and biliary sciences, Delhi, India

Role of Perfluorobutane in Lesion Detection, Targeting and Response Assessment for Ablation of HCC

Not Applicable
Completed
Conditions
Microwave Ablation
Hepatocellular Carcinoma
Interventions
First Posted Date
2021-10-05
Last Posted Date
2021-12-21
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
21
Registration Number
NCT05068076
Locations
šŸ‡®šŸ‡³

Institute of Liver & Biliary Sciences, New Delhi, Delhi, India

To Study Effect of the Combination of Midodrine and Tolvaptan Versus Tolvaptan Alone in Patients With Severe Hyponatremia in Cirrhosis(TOLMINA Trial)

Not Applicable
Conditions
Liver Cirrhosis
Interventions
First Posted Date
2021-09-29
Last Posted Date
2021-11-29
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
220
Registration Number
NCT05060523
Locations
šŸ‡®šŸ‡³

Institute of Liver & Biliary Sciences, New Delhi, Delhi, India

Ā© Copyright 2025. All Rights Reserved by MedPath